Financial Statements — EVGN
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 8.33 | 9.48 | 20.23 | 28.87 | 42.76 |
| Inventory | 1.96 | 0.79 | 0.25 | 0.16 | -- |
| Total Current Assets | 28.65 | 25.77 | 35.72 | 37.71 | 67.87 |
| Total Non-current Assets | 5.28 | 15.19 | 17.62 | 18.96 | 19.67 |
| Total Assets | 33.93 | 40.97 | 53.34 | 56.66 | 87.54 |
| Total Current Liabilities | 15.19 | 16.29 | 6.39 | 5.54 | 5.33 |
| Total Non-current Liabilities | 6.36 | 4.74 | 15.84 | 5.72 | 5.57 |
| Total Liabilities* | 21.55 | 21.03 | 22.23 | 11.27 | 10.89 |
| Retained Earnings | (281.12) | (266.87) | (247.00) | (224.16) | (192.09) |
| Total Stockholder Equity | 12.38 | 19.94 | 31.11 | 45.40 | 76.64 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Total Revenue | 3.23 | 5.10 | 1.30 | 0.55 | 0.47 |
| Cost of Revenue* | 1.65 | 0.85 | 0.78 | 0.43 | 0.40 |
| Gross Profit | 1.57 | 4.26 | 0.51 | 0.12 | 0.07 |
| Research & Development | 4.79 | 8.82 | 10.17 | 11.04 | 9.28 |
| Selling, General & Admin | 2.26 | 3.18 | 3.31 | 3.27 | 3.25 |
| Total Operating Expenses | 7.67 | 14.45 | 15.21 | 16.19 | 13.77 |
| Operating Income | (6.10) | (10.19) | (14.70) | (16.06) | (13.70) |
| Pretax Income | (5.43) | (9.83) | (14.78) | (18.82) | (14.01) |
| Tax Provision | 0.00 | 0.00 | (0.02) | 0.04 | 0.01 |
| Net Income | (7.67) | (9.83) | (14.76) | (18.86) | (14.02) |
| Basic EPS | -- | (1.82) | (0.32) | -- | -- |
| Diluted EPS | -- | (1.82) | (0.32) | (0.42) | -- |
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | (7.48) | (9.56) | (11.33) | (14.36) | (10.82) |
| Investing Cash Flow | (3.43) | (1.15) | (7.60) | 13.74 | (20.99) |
| Financing Cash Flow | 3.99 | (0.52) | 10.50 | (0.47) | 28.43 |
